Summary
Galderma SA (Galderma) is a pharmaceutical company. It develops and markets drugs, medical dermatology solutions and therapeutic skin care products for the treatment of hair, nail, and skin diseases. Galderma offers products for the treatment of skin conditions such as seborrheic dermatitis, androgenetic alopecia, glabellar lines, dry skin, acne, psoriasis, atopic dermatitis and steroid responsive dermatoses, onychomycosis, rosacea, and skin cancer. The company offers products leading brands such as Azzalure, Cetaphil, Clobex, Macrolane, and Oracea among several others. It markets products in India, Greece, Italy, Canada, Chile, Poland, the UK, and the US, among others. The company operates manufacturing facilities in France, Sweden, Canada, Brazil, Germany and Switzerland and research and development (R&D) centers in France, Sweden, the United States, Switzerland and Japan. Galderma is headquartered in Lausanne, Switzerland.
Galderma SA - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Galderma SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Galderma SA, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Galderma SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Galderma SA, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Galderma SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Galderma SA, Medical Equipment, Deal Details 10
Asset Purchase 10
Galderma Completes Acquisition of Aesthetic Dermatology Assets from Valeant Pharma for USD1.4 Billion 10
Partnerships 11
Galderma Enters into Agreement with ZELTIQ Aesthetics 11
Galderma Enters into Agreement with ImaBiotech 11
Asset Transactions 12
Bioventus To Acquire Durolane Assets From Galderma 12
Acquisition 13
Galderma Acquires Q-Med 13
Galderma SA - Key Competitors 16
Key Employees 17
Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 21
Corporate Communications 21
Dec 20, 2016: Appointment of Nestle Skin Health CEO ad interim 21
Other Significant Developments 22
Jun 10, 2016: Galderma Celebrates 20th Global Anniversary of Restylane 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23
List of Tables
Galderma SA, Medical Equipment, Key Facts 1
Galderma SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
Galderma SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Galderma SA, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Galderma SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Galderma SA, Deals By Market, 2011 to YTD 2017 8
Galderma SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Galderma Completes Acquisition of Aesthetic Dermatology Assets from Valeant Pharma for USD1.4 Billion 10
Galderma Enters into Agreement with ZELTIQ Aesthetics 11
Galderma Enters into Agreement with ImaBiotech 11
Bioventus To Acquire Durolane Assets From Galderma 12
Galderma Acquires Q-Med 13
Galderma SA, Key Competitors 16
Galderma SA, Key Employees 17
Galderma SA, Other Locations 18
Galderma SA, Subsidiaries 18
List of Figures
Galderma SA, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
Galderma SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
Galderma SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
Galderma SA, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
Galderma SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Galderma SA, Medical Equipment, Deals by Type, 2011 to YTD 2017 6
Galderma SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Galderma SA, Medical Equipment, Deals by Market, 2011 to YTD 2017 8